Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
141.65
-3.65 (-2.51%)
At close: Jan 16, 2026, 4:00 PM EST
141.90
+0.25 (0.18%)
After-hours: Jan 16, 2026, 7:55 PM EST
Illumina Market Cap
Illumina has a market cap or net worth of $21.64 billion as of January 16, 2026. Its market cap has increased by 2.13% in one year.
Market Cap
21.64B
Enterprise Value
22.94B
1-Year Change
2.13%
Ranking
Category
Stock Price
$141.65
Market Cap Chart
Since July 28, 2000, Illumina's market cap has increased from $1.24B to $21.64B, an increase of 1,651.85%. That is a compound annual growth rate of 11.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 21.64B | 8.00% |
| Dec 31, 2025 | 20.04B | -5.44% |
| Dec 31, 2024 | 21.19B | -4.15% |
| Dec 29, 2023 | 22.11B | -30.48% |
| Dec 30, 2022 | 31.81B | -46.51% |
| Dec 31, 2021 | 59.46B | 10.08% |
| Dec 31, 2020 | 54.02B | 10.77% |
| Dec 31, 2019 | 48.77B | 10.61% |
| Dec 31, 2018 | 44.09B | 38.21% |
| Dec 29, 2017 | 31.90B | 69.60% |
| Dec 30, 2016 | 18.81B | -33.07% |
| Dec 31, 2015 | 28.10B | 7.21% |
| Dec 31, 2014 | 26.21B | 87.51% |
| Dec 31, 2013 | 13.98B | 104.45% |
| Dec 31, 2012 | 6.84B | 84.71% |
| Dec 30, 2011 | 3.70B | -53.27% |
| Dec 31, 2010 | 7.92B | 106.38% |
| Dec 31, 2009 | 3.84B | 19.06% |
| Dec 31, 2008 | 3.22B | -0.56% |
| Dec 31, 2007 | 3.24B | 77.31% |
| Dec 29, 2006 | 1.83B | 215.10% |
| Dec 30, 2005 | 580.20M | 60.72% |
| Dec 31, 2004 | 361.00M | 55.87% |
| Dec 31, 2003 | 231.60M | 111.51% |
| Dec 31, 2002 | 109.50M | -71.10% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |